Drug Interaction Checker
Pharmacogenomic drug interactions and safety alerts
2
Critical Interactions
5
Moderate Interactions
3
Minor Interactions
Drug-Gene Interactions
Based on patient genetic profile
Warfarin
critical
Gene: CYP2C9
Recommendation:
Reduced starting dose recommended. Monitor INR closely.
Evidence: PharmGKB Level 1A
Codeine
moderate
Gene: CYP2D6
Recommendation:
Consider alternative analgesic. Reduced efficacy expected.
Evidence: FDA Label
Simvastatin
moderate
Gene: SLCO1B1
Recommendation:
Increased myopathy risk. Consider dose reduction or alternative statin.
Evidence: CPIC Guideline